|1.||Dewberry, Helen: 3 articles (01/2008 - 09/2003)|
|2.||Eliseeva, E V: 3 articles (01/2003 - 08/2000)|
|3.||Nefedov, V B: 3 articles (01/2001 - 01/2000)|
|4.||Grzesiak, Mariusz: 2 articles (01/2013 - 01/2013)|
|5.||Forys, Sebastian: 2 articles (01/2013 - 01/2013)|
|6.||Ahmed, Rehana B: 2 articles (01/2013 - 01/2013)|
|7.||Wilczynski, Jan: 2 articles (01/2013 - 01/2013)|
|8.||Wainer, Irving W: 2 articles (10/2012 - 11/2006)|
|9.||Lakatta, Edward G: 2 articles (04/2012 - 10/2011)|
|10.||Ahmet, Ismayil: 2 articles (04/2012 - 10/2011)|
|1.||Asthma (Bronchial Asthma)
03/01/1998 - "In a previous study of 64 asthmatics, most experienced a deterioration in asthma control during regular inhaled beta2-agonist (fenoterol) treatment, while a minority improved. "
12/01/1977 - "The therapeutic efficacy of fenoterol was sustained throughout this three-month study, and suggests that this relatively selective beta2 adrenergic drug will provide a well tolerated, alternative aerosol for chronic use in asthma."
01/01/1978 - "Fenoterol: a review of its pharmacological properties and therapeutic efficacy in asthma."
01/01/1993 - "The effect of different mouth pieces on efficacy of fenoterol was studied in 40 patients with atopic and non-atopic bronchial asthma with reversible bronchial constriction. "
01/01/2003 - "Time series studies suggested an association between the relatively nonselective beta-agonist fenoterol and asthma deaths. "
|2.||Chronic Obstructive Pulmonary Disease (COPD)
07/01/1985 - "Pretreatment with 600 micrograms of aerosolized fenoterol significantly improved the PD20FEV1 values in 11 subjects with COPD (1.26 to 6.16 mumol; p less than 0.001). "
01/01/2004 - "To study the effects of nebuliser therapy with berotek on clinical symptoms, external respiration function (ERF), bronchial permeability, hemodynamics and their temporal organisation in elderly patients with chronic obstructive pulmonary disease (COPD). "
02/01/1997 - "This study was designed to examine whether fenoterol increases the HVR and HCVR in patients with COPD. "
01/01/1995 - "As an example of beta 2-agonists fenoterol was used in this study on 27 patients with chronic obstructive airways diseases (COAD). "
01/01/1983 - "Ten patients with chronic obstructive lung disease entered the study, which showed no statistically significant difference between the effect of these two forms of the drug on lung function and pulse rate for a period of up to 6 hours after the inhalation of fenoterol. "
|3.||Exercise-Induced Asthma (Asthma, Exercise Induced)
01/01/1983 - "Eighteen adult asthmatics participated in a placebo controlled, double-blind, randomised study comparing the efficacy of pretreatment with fenoterol administered by pressurized aerosol and as a dry powder on exercise-induced asthma. "
01/01/1983 - "Fifteen adult asthmatics participated in a controlled open randomized study to compare the efficacy on exercise-induced asthma of pretreatment with 1 mg fenoterol administered as inhalation powder and from a pressurized aerosol. "
05/01/1993 - "The effect of 10, 50 and 200 micrograms inhaled fenoterol on exercise induced asthma."
04/01/1984 - "The effectiveness of inhaled fenoterol doses of 0.4 mg and 0.8 mg in preventing exercise-induced asthma was investigated in 12 patients. "
04/01/1984 - "Fenoterol in exercise-induced asthma. "
01/01/1984 - "The study showed that both fenoterol formulations possess a protective effect in allergen-induced bronchospasm. "
01/01/1984 - "The purpose of this study was to determine the level of protection afforded by fenoterol (200 microgram), administered by pressurized aerosol, in allergen-induced bronchospasm and to compare its effect with that of the same drug administered at the same dosage in powder form. "
11/01/1983 - "A trial of fenoterol for nocturnal bronchospasm."
01/01/1983 - "The purpose of this study was to determine the intensity and duration of the protective effect of fenoterol (200 micrograms) in allergen-induced bronchospasm and to compare its effect with that of DSCG (20 mg). "
01/01/1986 - "All were in a relatively stable clinico-functional state, and bronchospasm was reversible with fenoterol. "
|5.||Airway Obstruction (Choking)
01/01/1999 - "An airway obstruction was diagnosed when MEF50 < 60% of predicted value or Raw > 0.3 kPa/lxs-1. To assess airway obstruction reversibility test with fenoterol was performed. "
01/01/1995 - "The bronchodilation response induced by fenoterol reaches the same values with different routes of administration and depends on the amount of decrease of airway obstruction. "
09/01/1981 - "In an attempt to find the optimal single therapeutic dose of fenoterol inhalant solution administered by compressor-powered nebulization, bronchodilator and side effects of five different doses of fenoterol (0.5, 1.0, 1.5, 2.0, and 2.5 mg) and of placebo were compared with those of the recommended therapeutic dose delivered from a metered dose canister in 16 patients with reversible airway obstruction. "
01/01/1976 - "In 10 patients with airway obstruction, spirographic indices and maximal expiratory flow rates were measured before inhalation of fenoterol and at different time intervals, for 5 h, following the inhalation of 200 mug of this substance. "
03/01/1984 - "We have studied the effect of fenoterol, a selective beta-2 adrenergic agent, on airway obstruction in children with asthma. "
|1.||Ipratropium (Ipratropium Bromide)
|5.||Cromolyn Sodium (Cromoglicic Acid)
|6.||Histamine (Histamine Dihydrochloride)
|8.||ipratropium drug combination fenoterol
|1.||Nebulizers and Vaporizers (Inhaler)
|3.||Intermittent Positive-Pressure Breathing
|5.||Drug Therapy (Chemotherapy)